Cargando…
Developments in the management of psychosis: key evidence from 2022
ABSTRACT: The field of treatment and understanding in psychosis is evolving at an unprecedented pace with advances in neuroscience. It takes time before research findings are translated to clinical practice. Daunting as it is, clinicians need to keep up with findings which change our practice straig...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377441/ http://dx.doi.org/10.1192/j.eurpsy.2023.38 |
_version_ | 1785079518582538240 |
---|---|
author | Chakraborty, N. |
author_facet | Chakraborty, N. |
author_sort | Chakraborty, N. |
collection | PubMed |
description | ABSTRACT: The field of treatment and understanding in psychosis is evolving at an unprecedented pace with advances in neuroscience. It takes time before research findings are translated to clinical practice. Daunting as it is, clinicians need to keep up with findings which change our practice straightaway (new medication), findings which suggest that changes are expected in future (new theories about how illness develops and can be predicted) and findings which remind us of continuing practice and the evidence behind them (long term follow-up studies which give no big surprises but consolidate existing knowledge). In a snap shot, I bring to you a range of five papers published in 2022 which enrich our understanding of psychosis, its development and treatment. DISCLOSURE OF INTEREST: None Declared |
format | Online Article Text |
id | pubmed-10377441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103774412023-07-29 Developments in the management of psychosis: key evidence from 2022 Chakraborty, N. Eur Psychiatry Abstract ABSTRACT: The field of treatment and understanding in psychosis is evolving at an unprecedented pace with advances in neuroscience. It takes time before research findings are translated to clinical practice. Daunting as it is, clinicians need to keep up with findings which change our practice straightaway (new medication), findings which suggest that changes are expected in future (new theories about how illness develops and can be predicted) and findings which remind us of continuing practice and the evidence behind them (long term follow-up studies which give no big surprises but consolidate existing knowledge). In a snap shot, I bring to you a range of five papers published in 2022 which enrich our understanding of psychosis, its development and treatment. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10377441/ http://dx.doi.org/10.1192/j.eurpsy.2023.38 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Chakraborty, N. Developments in the management of psychosis: key evidence from 2022 |
title | Developments in the management of psychosis: key evidence from 2022 |
title_full | Developments in the management of psychosis: key evidence from 2022 |
title_fullStr | Developments in the management of psychosis: key evidence from 2022 |
title_full_unstemmed | Developments in the management of psychosis: key evidence from 2022 |
title_short | Developments in the management of psychosis: key evidence from 2022 |
title_sort | developments in the management of psychosis: key evidence from 2022 |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377441/ http://dx.doi.org/10.1192/j.eurpsy.2023.38 |
work_keys_str_mv | AT chakrabortyn developmentsinthemanagementofpsychosiskeyevidencefrom2022 |